Pictet Bank & Trust LTD Eli Lilly & CO Transaction History

Pictet Bank & Trust LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 02, 2019	SELL	$111.31 - $131.02 $812,563 - $956,446	-7,300 Closed	0 $0
Q4 2018 Jan 31, 2019	SELL	$105.9 - $118.64 $1.68 Million - $1.89 Million	-15,900 Reduced 68.53%	7,300 $845,000
Q2 2018 Aug 09, 2018	BUY	$75.7 - $86.88 $15,140 - $17,376	200 Added 0.87%	23,200 $1.98 Million
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $245,820 - $263,670	-3,000 Reduced 11.54%	23,000 $1.94 Million
Q3 2017 Nov 07, 2017	SELL	$77.07 - $85.54 $61,655 - $68,432	-800 Reduced 2.99%	26,000 $2.22 Million

Q2 2017 Aug 09, 2017	BUY	N/A	26,800	26,800 $2.21 Million

3,727

738M

7.09M

7.24M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $886B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Pictet Bank & Trust LTD, based on Form 13F filings with the SEC.

Stay updated on Pictet Bank & Trust LTD with notifications on news.